लोड हो रहा है...
Novel pharmacotherapies in diabetic retinopathy: Current status and what's in the horizon?
The blood–retinal barrier (BRB) alteration is the hallmark feature of diabetic retinopathy. Vascular endothelial growth factor (VEGF) is a potent vasopermeability factor that has been implicated in the pathogenesis of BRB alteration. Inflammation also plays a crucial role in this process with involv...
में बचाया:
| में प्रकाशित: | Indian J Ophthalmol |
|---|---|
| मुख्य लेखकों: | , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Medknow Publications & Media Pvt Ltd
2016
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4821120/ https://ncbi.nlm.nih.gov/pubmed/26953018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0301-4738.178154 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|